
Advanced Enzyme Technologies Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-05-21 08:03:48Advanced Enzyme Technologies Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The company’s stock, currently trading at ₹387.90, has seen a positive day change of 0.57%, reflecting growing investor confidence amid improving technical signals and a recent upgrade in its Mojo Grade from Sell to Hold.
Read More
Golden Cross Confirmed: Do Advanced Enzyme Technologies Ltd's Other Technical Indicators Agree?
2026-05-20 18:00:34The 50-day moving average has crossed above the 200-day moving average for Advanced Enzyme Technologies Ltd, signalling a golden cross on 20 May 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.
Read More
Broad-Based Technical Strength Lifts Advanced Enzyme Technologies Ltd to 52-Week High of Rs 412.5
2026-05-11 09:44:59With a decisive surge to Rs 412.5 on 11 May 2026, Advanced Enzyme Technologies Ltd has reached a fresh 52-week high, marking a 42.79% gain over the past year. This rally stands out amid a broadly declining Sensex, which has slipped 3.94% over the same period, underscoring the stock’s robust price momentum and technical strength.
Read More
Advanced Enzyme Technologies Ltd Surges 13.35% to Day's High of Rs 412.5 — Outperforms Sector by 12.86 Percentage Points
2026-05-11 09:31:10While the Sensex declined by 1.06% on 11 May 2026, Advanced Enzyme Technologies Ltd surged 13.35%, reaching an intraday high of Rs 412.5. This remarkable 12.86 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally in an otherwise weak market environment.
Read MoreAre Advanced Enzyme Technologies Ltd latest results good or bad?
2026-05-10 19:12:42Advanced Enzyme Technologies Ltd reported its financial results for the quarter ended March 2026, showcasing notable growth in both net sales and consolidated net profit. The company achieved consolidated net profit of ₹42.96 crores, reflecting a year-on-year growth of 62.24% compared to ₹26.48 crores in the same quarter last year. This indicates a strong recovery from a prior decline in net profit of -6.46% in March 2025. Net sales for the quarter reached ₹203.37 crores, marking a 21.65% increase from ₹167.18 crores in the previous year. This growth is attributed to heightened demand across the company's enzyme portfolio, particularly in human and animal nutrition segments. The operating profit before depreciation, interest, and tax (excluding other income) also saw significant improvement, reaching ₹63.23 crores, which is the highest on record for the company. The operating margin for the quarter stood...
Read More
Advanced Enzyme Technologies Ltd is Rated Hold
2026-05-09 10:10:03Advanced Enzyme Technologies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into its performance and valuation.
Read More
Broad-Based Technical Strength Lifts Advanced Enzyme Technologies Ltd to 52-Week High of Rs 370.9
2026-05-08 09:45:28Surging past its previous peak, Advanced Enzyme Technologies Ltd touched a fresh 52-week high of Rs 370.9 on 8 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals that have aligned to propel the stock higher despite a broadly subdued market environment.
Read More
Broad-Based Technical Strength Lifts Advanced Enzyme Technologies Ltd to 52-Week High of Rs 366.95
2026-05-05 10:10:44With a decisive surge to Rs 366.95 on 5 May 2026, Advanced Enzyme Technologies Ltd has reached a fresh 52-week high, marking a 45.6% rise from its low of Rs 251.90 over the past year. This milestone reflects a sustained momentum driven by a confluence of technical indicators aligning favourably despite a broadly subdued market backdrop.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
12-Jun-2026 | Source : BSENewspaper Publication - Notice to Equity Shareholders of the Company regarding transfer of shares to the Investor Education and Protection Fund (IEPF) and Unclaimed Dividend thereto / Second 100 days Campaign - Saksham Niveshak for KYC and other related updation and shareholders engagement to prevent transfer of unpaid / uncalimed dividend to IEPF / Special window for transfer and dematerialisation of physical securities
Announcement under Regulation 30 (LODR)-Change in Directorate
11-Jun-2026 | Source : BSEPlease find enclosed herewith intimation regarding completion of second term of Ms. Rajshree Patel as Independent Director of the Company.
Announcement under Regulation 30 (LODR)-Updates on Acquisition
06-Jun-2026 | Source : BSEPlease find enclosed herewith the update regarding the additional investment in wholly owned subsidiary of the Company - Advanced Nutrazyme Private Limited.
Corporate Actions
No Upcoming Board Meetings
Advanced Enzyme Technologies Ltd has declared 60% dividend, ex-date: 23 Jul 25
Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17
No Bonus history available
No Rights history available
